Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output
| Auteurs | Dupuis-Girod S, Ginon I, Saurin J C, Marion D, Guillot E, Decullier E, Roux A, Carette M F, Gilbert-Dussardier B, Hatron P Y, Lacombe P, Lorcerie B, Riviere S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette P J, Plauchu H, Faure F |
| Revue | |
| Institut | iRTSV |
| Année | 2 012 |